Latest Breaking News On - Iv vaccine clinical trials - Page 1 : comparemela.com

MIT Professor Darrell Irvine describes a novel vaccine adjuvant: a nanoparticle that can help stimulate the immune system to generate a stronger response to a vaccine. An HIV vaccine with this adjuvant will be tested in clinical trials.

Darrell irvineBruce walkerPaula hammondScripps research instituteRagon instituteVaccine developmentScripps consortiumDepartment of chemical engineeringProfessor darrell irvineScripps researchIvan piresChemical engineeringVaccine adjuvantsNanoparticle adjuvantsIv vaccine clinical trialsDarrell irvine